Moderate to Severe Glabellar Lines Clinical Trial
Official title:
A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines
This is a phase 1/2, multicenter, randomized, double-blind, active-controlled and placebo-controlled study to evaluate safety, immunogenicity and efficacy of JHM03 for the treatment of moderate to severe glabellar lines in male and female subjects of Chinese origin. The purpose of this study was to observe efficacy and safety of JHM03 compared with placebo and BOTOX® in moderate to severe glabellar lines.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05743634 -
A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines
|
Phase 1/Phase 2 | |
| Completed |
NCT05463965 -
A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines
|
Phase 3 | |
| Completed |
NCT06151561 -
Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines
|
Phase 1 | |
| Completed |
NCT02353871 -
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
|
Phase 3 | |
| Completed |
NCT06354127 -
DWP450 for Treating Moderate to Severe Glabellar Lines
|
Phase 3 | |
| Completed |
NCT03970876 -
Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects
|
Phase 1/Phase 2 |